Clinical Trials Directory

Trials / Completed

CompletedNCT04823676

Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management

Efficacy and Safety of a Probiotic Composition as Adjunct Treatment in the Comprehensive Management of Metabolism-Associated Hepatic Steatosis in Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
AB Biotics, SA · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Some studies have shown beneficial results with probiotics on hepatic function of subjects with fatty liver, but significant variability has been noted among probiotic formulations. This study aims at providing a comprehensive characterization of the effect of a particular probiotic formula in hepatic function of said subjects.

Detailed description

Some studies have shown beneficial results with probiotics on hepatic function of subjects with Non-Alcoholic Fatty Liver (NAFL) also known as Metabolism-Associated Fatty Liver (MAFL). However, meta-analyses have found significant variability among probiotic formulations. In fact, many probiotic properties are thought to be strain-specific. This study aims at providing a comprehensive characterization of a particular probiotic formula containing Lactoplantibacillus plantarum (formerly Lactobacillus plantarum) and Levilactobacillus brevis (formerly Lactobacillus brevis) in hepatic function of individuals with NAFL. The study will assess hepatic stiffness via transient elastography (Fibroscan), hepatic function via liver enzymes in serum (ALT, AST, GGT) and liver-specific inflammation via cytokeratin18 in serum, as well as some general metabolic and inflammatory markers.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic compositionMixture of two Lactoplantibacillus plantarum strains (formerly Lactobacillus plantarum) and one Levilactobacillus brevis strain (formerly Lactobacillus brevis), in a maltodextrin carrier (E1400)
OTHERPlaceboMaltodextrin (E1400, qs)

Timeline

Start date
2021-03-31
Primary completion
2021-12-13
Completion
2022-02-22
First posted
2021-04-01
Last updated
2022-02-24

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04823676. Inclusion in this directory is not an endorsement.